Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
59.50
+0.02 (0.03%)
May 13, 2026, 12:37 PM EDT - Market open

KNSA Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
189.95165.6183.58107.95122.72122.47
Short-Term Investments
278.14248.4860.0598.4267.8959.73
Cash & Short-Term Investments
468.09414.07243.63206.37190.61182.2
Cash Growth
74.44%69.96%18.05%8.27%4.61%-43.68%
Accounts Receivable
23.2215.5941.7221.2712.663.99
Other Receivables
----7.66-
Total Trade Receivables
23.2215.5941.7221.2720.323.99
Inventory
73.1454.926.3631.1221.63.68
Other Current Assets
29.7142.6120.0817.5410.546.59
Total Current Assets
594.17527.18331.8276.3243.06196.45
Net Property, Plant & Equipment
11.3211.7511.0412.677.048.38
Other Intangible Assets
1515.2516.2517.2518.2519.25
Other Long-Term Assets
204.79209.46221.47220.11191.328.72
Total Assets
825.28763.63580.55526.32459.67232.8
Accounts Payable
24.42.032.048.257.91.87
Accrued Expenses
108.35112.0480.5144.6730.1138.03
Current Portion of Leases
3.172.991.992.253.33.38
Unearned Revenue
---0.31--
Other Current Liabilities
20.6922.1316.088.195.751.54
Total Current Liabilities
156.61139.18100.6263.6747.0744.82
Long-Term Leases
5.866.517.8610.012.622.67
Other Long-Term Liabilities
57.1350.3333.6313.8113.840.27
Total Long-Term Liabilities
62.9856.8441.523.8216.462.94
Total Liabilities
219.59196.03142.1287.4863.5247.76
Common Stock
0.020.020.0200.020.02
Additional Paid-in Capital
1,0461,030959.72916.76888.12860.48
Accumulated Other Comprehensive Income
-0.67-0.03-0.160.010.04-0.07
Retained Earnings
-439.55-462.14-521.14-477.95-492.03-675.4
Shareholders' Equity
605.69567.61438.44438.84396.15185.04
Total Liabilities & Equity
825.28763.63580.55526.32459.67232.8
Total Debt
9.039.59.8612.265.926.05
Net Cash (Debt)
459.07404.58233.77194.11184.69176.15
Net Cash Growth
13.47%73.06%20.43%5.10%4.85%-44.34%
Net Cash Per Share
5.705.123.272.702.622.57
Book Value
605.69567.61438.44438.84396.15185.04
Book Value Per Share
7.537.196.146.105.632.70
Tangible Book Value
590.69552.36422.19421.59377.9165.79
Tangible Book Value Per Share
7.346.995.915.865.372.42
Updated Apr 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q